SP-8203

· Shin Poong Pharmaceutical Co. Ltd.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for SP-8203, covering 2020-07-21 to 2023-03-08. Get the full timeline:

Most recent: Clinical Trial Update: Efficacy and Safety of SP-8203 in Patients With Ischemic Stroke Requiring rtPA [Phase 2]